Back to results
Completed

Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly

NCT00660088

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Meridien Research Center

St. Petersburg, Florida, United States

View on ClinicalTrials.gov
Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly — TrialFind